Quantum Genomics expands its US presence
5 February 2016 | By Victoria White
Quantum Genomics has established a US Clinical Advisory Board of renowned cardiologists and cardiovascular researchers...
List view / Grid view
News
Mice with increased levels of TTP resistant to inflammation
4 February 2016 | By Victoria White
Compounds that produce elevated levels of TTP in humans may offer an effective treatment for inflammatory diseases, such as rheumatoid arthritis and multiple sclerosis...
Potential new approaches to treating AMD
4 February 2016 | By Victoria White
Researchers have discovered that a pro-inflammatory signalling protein, called IL-33, shows increased expression in AMD...
Empty Hepatitis E virus shells used to carry vaccines
4 February 2016 | By Victoria White
Researchers showed that virus-like particles carrying LXY-30 could home in on breast cancer cells both in a laboratory dish and in a mouse model...
Selvita opens new research site in Poland
4 February 2016 | By Victoria White
The new site will be located at in the Wielkopolska Centre of Advanced Technologies, Poznan, and commence research activities in the summer of 2016...
Mersana and Takeda expand partnership to advance XMT-1522
3 February 2016 | By Victoria White
XMT-1522 is an investigational, Fleximer-based ADC therapy that targets HER2-expressing tumours, including breast, gastric and non-small cell lung cancers...
London Cancer Hub to accelerate the discovery of treatments
3 February 2016 | By Victoria White
A new ‘roadmap’ document published today outlines how The London Cancer Hub will become a world-leading life-science campus...
Teva and AbCellera team up to discover monoclonal antibodies
3 February 2016 | By Victoria White
AbCellera will apply its high-throughput single cell antibody platform for the discovery of the rare monoclonal antibodies...
Adaptimmune and GSK expand cancer immunotherapy collaboration
3 February 2016 | By Victoria White
The enhanced agreement will accelerate Adaptimmune’s lead clinical cancer programme, an affinity enhanced T-cell immunotherapy targeting NY-ESO-1...
Leicester’s Dr Echalier awarded Domainex’s Discovery STAR AWARD
3 February 2016 | By Victoria White
This award will give Dr Echalier access to the drug discovery capabilities of Domainex in support of her research...
MISSION Therapeutics raises £60m to advance DUB inhibitors
2 February 2016 | By Victoria White
The £60 million enables the company to maximise the potential of its DUB platform and advance a series of DUB inhibitors...
Non-coding RNA helps suppress breast cancer
2 February 2016 | By Victoria White
A team of scientists from Bath, Cambridge and the USA has identified a piece of non-coding RNA that stops cells turning cancerous...
Cell Therapy Catapult becomes Cell and Gene Therapy Catapult
2 February 2016 | By Victoria White
The Cell Therapy Catapult has changed its name to the Cell and Gene Therapy Catapult to more accurately reflect the activities of the organisation...
HFEA approves embryo gene editing
1 February 2016 | By Victoria White
The aim of the research is to understand the genes human embryos need to develop successfully...
Stem cells that can repair the skull and face bones
1 February 2016 | By Victoria White
Scientists have, for the first time, identified and isolated stem cells capable of skull formation and craniofacial bone repair in mice...
